![Alana McNulty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 36 475 $ in data 31/05/2026
Alana B. McNulty is currently an Independent Director at Janux Therapeutics, Inc. since 2021, a Director at Lipidio Pharmaceuticals, Inc. since 2023, and Chief Business Officer at eFFECTOR Therapeutics Operations, Inc. since 2021.
Former roles include Independent Director at NKGen Biotech, Inc. from 2023 to 2024, General Manager & Head-Corporate Development at Advanced Tissue Sciences, Inc. from 1991 to 1998, Associate-BioSciences Group at The Bear Stearns Cos., Inc., Chief Financial Officer & Vice President-Finance at Elitra Pharmaceuticals, Inc. from 1998 to 2003, Chief Financial Officer & Vice President-Finance at BrainCells, Inc. from 2004 to 2011, Chief Financial Officer at Lumena Pharmaceuticals, Inc. from 2012 to 2014, Chief Financial Officer at Excaliard Pharmaceuticals, Inc. in 2011, and Chief Business Officer at eFFECTOR Therapeutics, Inc. from 2020 to 2022.
Education includes undergraduate studies at the University of California, Santa Barbara and an MBA from UCLA Anderson School of Management.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/02/2026 | 2.500 ( 0% ) | 36 475 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 07/09/2021 |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Corporate Officer/Principal | 07/01/2021 |
Lipidio Pharmaceuticals, Inc.
 Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines | Direttore/Membro del Consiglio | 01/02/2023 |
| Società | Posizione | Fine |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/12/2020 |
Lumena Pharmaceuticals, Inc.
 Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for rare liver diseases | Direttore Finanziario/CFO | 01/11/2014 |
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops therapeutics for the treatment of scarring & fibrotic disorders | Direttore Finanziario/CFO | 01/11/2011 |
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Direttore Finanziario/CFO | 01/01/2011 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Advanced Tissue Sciences, Inc.
 Advanced Tissue Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human-based tissue products for therapeutic applications | Commercial Services |
The Bear Stearns Cos., Inc.
 The Bear Stearns Cos., Inc. Investment Banks/BrokersFinance Provides investment banking, securities trading and brokerage services | Finance |
Elitra Pharmaceuticals, Inc.
 Elitra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Lumena Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for rare liver diseases | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops therapeutics for the treatment of scarring & fibrotic disorders | Health Technology |
eFFECTOR Therapeutics Operations, Inc.
eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipidio Pharmaceuticals, Inc.
Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
